Efficacy and Safety of Argon Plasma Coagulation for the Ablation of Barrett’s Esophagus: A Systemic Review and Meta-Analysis

키워드

참고문헌 (52)

1. Mukaisho KI, "Barretts’s carcinogenesis", Pathol Int, 69, pp.319~330 (2019)
2. Elsheaita A, "Seattle protocol vs narrow band imaging guided biopsy in screening of Barrett’s esophagus in gastroesophageal reflux disease patients", Medicine(Baltimore), 99, pp.e19261~ (2020)
3. Que J, "Pathogenesis and cells of origin of Barrett’s esophagus", Gastroenterology, 157, pp.349~364 (2019)
4. Bennett C, "BOB CAT : a largescale review and Delphi consensus for management of Barrett’s esophagus with no dysplasia, indefinite for, or lowgrade dysplasia", Am J Gastroenterol, 110, pp.662~682 (2015)
5. Pandey G, "Systematic review and meta-analysis of the effectiveness of radiofrequency ablation in low grade dysplastic Barrett’s esophagus", Endoscopy, 50, pp.953~960 (2018)
6. Shaheen NJ, "Diagnosis and management of Barrett’s esophagus : an updated ACG guideline", Am J Gastroenterol, 117, pp.559~587 (2022)
7. Tan MC, "Factors associated with recurrence of Barrett’s esophagus after radiofrequency ablation", Clin Gastroenterol Hepatol, 17, pp.65~72 (2019)
8. Manner H, "The tissue effect of argon-plasma coagulation with prior submucosal injection(Hybrid-APC)versus standard APC : a randomized exvivo study", United European Gastroenterol J, 2, pp.383~390 (2014)
9. Page MJ, "The PRISMA 2020statement : an updated guideline for reporting systematic reviews", BMJ, 372, pp.n71~ (2021)
10. Giri S, "Efficacy and safety of transjugular intrahepatic portosystemic shunt creation for Budd-Chiari syndrome : a systematic review and meta-analysis", J Vasc Interv Radiol, 33, pp.1301~1312 (2022)
11. Morris CD, "Prevention of the neoplastic progression of Barrett’s oesophagus by endoscopic argon beam plasma ablation", Br J Surg, 88, pp.1357~1362 (2001)
12. Basu KK, "Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett’s oesophagus : factors determining persistence and recurrence of Barrett’s epithelium", Gut, 51, pp.776~780 (2002)
13. Kahaleh M, "Long-term follow-up and factors predictive of recurrence in Barrett’s esophagus treated by argon plasma coagulation and acid suppression", Endoscopy, 34, pp.950~955 (2002)
14. Familiari L, "Endoscopic treatment of Barrett’s epithelium with argon plasma coagulation : long-term follow-up", Minerva Gastroenterol Dietol, 49, pp.63~70 (2003)
15. Morino M, "Endoscopic ablation of Barrett’s esophagus using argon plasma coagulation(APC)following surgical laparoscopic fundoplication", Surg Endosc, 17, pp.539~542 (2003)
16. Pagani M, "Barrett’s esophagus : combined treatment using argon plasma coagulation and laparoscopic antireflux surgery", Dis Esophagus, 16, pp.279~283 (2003)
17. Ackroyd R, "Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett’s esophagus after antireflux surgery", Gastrointest Endosc, 59, pp.1~7 (2004)
18. Dulai GS, "Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett’s esophagus", Gastrointest Endosc, 61, pp.232~240 (2005)
19. Ragunath K, "Endoscopic ablation of dysplastic Barrett’s oesophagus comparing argon plasma coagulation and photodynamic therapy : a randomized prospective trial assessing efficacy and cost-effectiveness", Scand J Gastroenterol, 40, pp.750~758 (2005)
20. Sharma P, "A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression : long term results", Gut, 55, pp.1233~1239 (2006)
21. Ferraris R, "Barrett’s oesophagus : long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence", Aliment Pharmacol Ther, 25, pp.835~840 (2007)
22. Mörk H, "High recurrence rate of Barrett’s epithelium during long-term follow-up after argon plasma coagulation", Scand J Gastroenterol, 42, pp.23~27 (2007)
23. Migaczewski M, "Argon plasma coagulation(APC)for treatment of Barrett’s oesophagus", Videosurg Other Miniinvasive Tech, 4, pp.102~109 (2009)
24. Bright T, "Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett’s esophagus in patients treated with antisecretory medication", Dig Dis Sci, 54, pp.2606~2611 (2009)
25. Zhang L, "Endoscopic ablation of Barrett’s esophagus using the second generation argon plasma coagulation : a prospective randomized controlled trail", J Nanjing Med Univ, 23, pp.183~188 (2009)
26. Sie C, "Argon plasma coagulation ablation versus endoscopic surveillance of Barrett’s esophagus : late outcomes from two randomized trials", Endoscopy, 45, pp.859~865 (2013)
27. Castaño R, "Argon plasma ablation versus band mucosectomy for endoscopic management of Barrett’s esophagus with dysplasia or esophageal carcinoma", Rev Colomb Gastroenterol, 29, pp.358~367 (2014)
28. Milashka M, "Sixteenyear follow-up of Barrett’s esophagus, endoscopically treated with argon plasma coagulation", United European Gastroenterol J, 2, pp.367~373 (2014)
29. Szachnowicz S, "Long-term follow up of patients submitted to argon plasma coagulation of non dysplastic Barrett’s esophagus after Nissen fundoplication", JSM Gastroenterol Hepatol, 4, pp.1066~ (2016)
30. Michopoulos S, "Use of argon plasma coagulation(APC)for endoscopic eradication therapy of dysplastic Barrett’s esophagus(BE)in the clinical practice", Gastrointest Endosc, 95, pp.AB368~ (2022)
31. Pereira-Lima JC, "High power setting argon plasma coagulation for the eradication of Barrett’s esophagus", Am J Gastroenterol, 95, pp.1661~1668 (2000)
32. Schulz H, "Ablation of Barrett’s epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole", Gastrointest Endosc, 51, pp.659~663 (2000)
33. Van Laethem JL, "Argon plasma coagulation in the treatment of Barrett’s high-grade dysplasia and in situ adenocarcinoma", Endoscopy, 33, pp.257~261 (2001)
34. Tigges H, "Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett’s esophagus", J Gastrointest Surg, 5, pp.251~259 (2001)
35. Attwood SE, "Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett’s esophagus", Clin Gastroenterol Hepatol, 1, pp.258~263 (2003)
36. Madisch A, "Long-term follow-up after complete ablation of Barrett’s esophagus with argon plasma coagulation", World J Gastroenterol, 11, pp.1182~1186 (2005)
37. Pedrazzani C, "Endoscopic ablation of Barrett’s esophagus using high power setting argon plasma coagulation : a prospective study", World J Gastroenterol, 11, pp.1872~1875 (2005)
38. Brasil HA, "S1521 : Argon plasma coagulation in Barrett’s epithelium ablation : does the power setting matter? A long term prospective study", Gastrointest Endosc, 71, pp.AB184~ (2010)
39. Dotti VP, "Endoscopic argon plasma thermo-coagulation of Barrett’s esophagus using different powers: histopathological and post procedure symptons analysis", Rev Col Bras Cir, 36, pp.110~117 (2009)
40. Wronska E, "Argon plasma coagulation for Barrett’s esophagus with low-grade dysplasia : a randomized trial with long-term follow-up on the impact of power setting and proton pump inhibitor dose", Endoscopy, 53, pp.123~132 (2021)
41. Kashin SV, "Mo2016 The new hybrid argon plasma coagulation(hybrid APC)for endoscopic ablation of Barrett’s esophagus(BE) : the results of the pilot trial", Gastrointest Endosc, 83, pp.AB495~ (2016)
42. Manner H, "Efficacy and safety of hybrid-APC for the ablation of Barrett’s esophagus", Surg Endosc, 30, pp.1364~1370 (2016)
43. Linn B, "Mo1278 Hybrid argon plasma coagulation and radiofrequency ablation in Barrett’s esophagus", Gastrointest Endosc, 91, pp.AB413~ (2020)
44. Trindade AJ, "Successful treatment of refractory Barrett’s neoplasia with hybrid argon plasma coagulation : a case series", Endoscopy, 52, pp.812~813 (2020)
45. Kroupa R, "Hybrid argon plasma coagulation in the ablation treatment of Barrett’s esophagus-long term results", United European Gastroenterol J, 9, pp.297~298 (2021)
46. Shimizu T, "Benefit, tolerance, and safety of hybrid argon plasma coagulation for treatment of Barrett’s esophagus : US pilot study", Endosc Int Open, 9, pp.E1870~E1876 (2021)
47. Staudenmann DA, "Safety and long-term efficacy of hybrid-argon plasma coagulation for the treatment of Barrett’s esophagus : an Australian pilot study(with video)", Int J Gastrointest Interv, 10, pp.128~132 (2021)
48. Knabe M, "Hybrid APC in combination with resection for the endoscopic treatment of neoplastic Barrett’s esophagus : a prospective, multicenter study", Am J Gastroenterol, 117, pp.110~119 (2022)
49. McColl KE, "What is causing the rising incidence of esophageal adenocarcinoma in the West and will it also happen in the East?", J Gastroenterol, 54, pp.669~673 (2019)
50. Tariq R, "Efficacy of cryotherapy as a primary endoscopic ablation modality for dysplastic Barrett’s esophagus and early esophageal neoplasia : a systematic review and meta-analysis", Cancer Control, 27, pp.1073274820976668~ (2020)
51. Qumseya BJ, "Adverse events after radiofrequency ablation in patients with Barrett’s esophagus : a systematic review and meta-analysis", Clin Gastroenterol Hepatol, 14, pp.1086~1095 (2016)
52. Knabe M, "Hybrid argon plasma coagulation versus radiofrequency ablation after endoscopic resection of neoplastic lesions in Barrett's esophagus : a randomized trial at a tertiary center", Gastroenterol, 58, pp.e142~ (2020)

관련 논문AI추천